Hanmi's Slimmer is spotlighted in Japan

Published: 2007-10-08 06:57:00

Updated: 2007-10-08 06:57:00

Hanmi Pharm's Slimmer (sibutramine mesylate), a generic anti-obesity drug of Reductil (sibutramine), is a forerunner in domestic weight loss drug market, according to Japan's prominently daily Sankei Shinmoon.

It took four years for Hammi to develop Slimmer with an investment of 3.7 billion wo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK